China News Agency, Beijing, September 14 (Reporter Liu Yuying) According to data disclosed by the Ministry of Industry and Information Technology of China on the 14th, China's annual production capacity of the new coronavirus vaccine exceeds 7 billion doses, and the output exceeds 5.5 billion doses.
He Yaqiong, Director of the Consumer Goods Industry Department of the Ministry of Industry and Information Technology of China, introduced at the press conference on the theme of "Promoting the Consumer Goods Industry to Increase Varieties, Improve Quality and Create Brands" held on the same day. The Ministry of Industry and Information Technology communicated with the provinces, autonomous regions and municipalities where the epidemic occurred as soon as possible, strengthened the production scheduling of key medical materials such as new coronavirus detection reagents, protective equipment, therapeutic drugs and vaccines, and closely tracked and monitored the production and supply of key enterprises.
Up to now, the weekly production capacity of key manufacturers of antigen testing has exceeded 500 million copies, the weekly production capacity of key manufacturers of nucleic acid testing has exceeded 200 million copies, the weekly production capacity of key manufacturers of N95/KN95 masks has exceeded 100 million, and the weekly production capacity of key manufacturers of protective clothing More than 3 million pieces, the weekly production capacity of Azvudine exceeds 700,000 doses, the annual production capacity of the new coronavirus vaccine exceeds 7 billion doses, and the output exceeds 5.5 billion doses, which can meet the needs of the current epidemic prevention and control situation.
He Yaqiong said that in the next step, the Ministry of Industry and Information Technology will continue to improve the production scheduling and supply guarantee of key medical materials, strengthen the precise connection between supply and demand, and ensure timely and sufficient supply; closely track the progress of new detection reagents, therapeutic drugs and vaccines, and guide enterprises to do a good job in scale in a timely manner. preparations for production; support enterprises to carry out international cooperation and assist developing countries to enhance local production capacity.
(Finish)